Program
formoterol
Also written as “Formoterol Fumarate”, “budesonide/formoterol” and “Formoterol”.
Its studies are mostly in Asthma · Pulmonary Disease, Chronic Obstructive · Bronchitis, Chronic · Asthma, Exercise-Induced, led by 18 companies.
Drug pageFormoterol: every studyMany companies study it; this page follows only the 137 they lead. All 190 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| AstraZeneca | 632 open or running | phase 4since Jan 4, 2006 | Sep 13, 2005 | May 31, 2027phase 4 · NCT07073950 |
| Chiesi Farmaceuticiits history only | 200 open or running | phase 4since Nov 29, 2010 | Oct 30, 2006 | none ahead |
| Viatrisits history only | 160 open or running | phase 4since Nov 29, 2011 | Sep 13, 2005 | none ahead |
| Novartisits history only | 60 open or running | phase 4since Jul 26, 2005 | Jul 26, 2005 | none ahead |
| Sumitomo Pharmaits history only | 60 open or running | phase 4since Jan 17, 2007 | Jul 8, 2003 | none ahead |
| SkyePharmaits history only | 50 open or running | phase 3since Oct 27, 2006 | Oct 27, 2006 | none ahead |
| Eurofarma Laboratoriosits history only | 30 open or running | phase 3since Oct 23, 2009 | Oct 23, 2009 | none ahead |
| Mundipharmaits history only | 30 open or running | phase 4since Jun 15, 2015 | Oct 14, 2009 | none ahead |
| Ache Laboratorios Farmaceuticosits history only | 20 open or running | phase 3since Mar 9, 2011 | Mar 9, 2011 | none ahead |
| Boehringer Ingelheimits history only | 20 open or running | phase 2since Sep 11, 2014 | Sep 11, 2014 | none ahead |
| Intech Biopharmits history only | 20 open or running | phase 1since Jul 25, 2016 | Jul 25, 2016 | none ahead |
| Orion Corporation, Orion Pharmaits history only | 20 open or running | phase 2since Aug 24, 2009 | Aug 24, 2009 | none ahead |
| Zambon SpAits history only | 20 open or running | phase 1since Sep 2, 2014 | Sep 2, 2014 | none ahead |
| Chenpon Pharmaceuticalits history only | 10 open or running | phase 3since Aug 24, 2026 | Aug 24, 2026 | none ahead |
| Kindeva Drug Deliveryits history only | 10 open or running | phase 3since Jan 6, 2017 | Jan 6, 2017 | none ahead |
| Merckits history only | 10 open or running | phase 4since Aug 30, 2005 | Aug 30, 2005 | none ahead |
| Neutec Ar-Ge San ve Tic A.Şits history only | 10 open or running | phase 4since Oct 6, 2016 | Oct 6, 2016 | none ahead |
| Teva Pharmaceutical Industriesits history only | 10 open or running | phase 3since Jul 1, 2015 | Jul 1, 2015 | none ahead |
Also a collaborator on its studies: Parexel, CISCRP, eResearchTechnology, Menarini Group, Integrated Therapeutics Group and Pacira BioSciences.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of AstraZeneca only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 44 studies since Oct 12, 2005.
- Feb 17, 2016Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03262012 · 416 enrolled · Japan
- May 6, 20162 phase 3 studies in Pulmonary Disease, Chronic ObstructiveNCT02766608, NCT02796677
- Jun 7, 2016Phase 2 study in Pulmonary Disease, Chronic ObstructiveNCT02796651 · 132 enrolled · United States
- Jan 13, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03022097 · 1,625 enrolled · China, India, Philippines and more
- Apr 26, 2017Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT03181880
- May 19, 2017Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03162055 · 1,119 enrolled · United States, Bulgaria, Canada and more
- Sep 24, 2018Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT03836677 · 23 enrolled · Belgium, Netherlands
- Oct 26, 20202 phase 3 studies in AsthmaNCT04609904, NCT04609878
- Jan 10, 2022Phase 3 study in AsthmaNCT05202262 · 645 enrolled · United States, Canada, Germany and more
- Feb 23, 2023Phase 3 study in AsthmaNCT05755906 · 374 enrolled · United States, Canada, Czechia and more
- Sep 28, 2023Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT06067828 · 171 enrolled · United States, Canada, China and more
- Feb 21, 2024Phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT06283966 · 5,250 planned · United States, Argentina, Australia and more
- Jul 17, 2025Phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT07073950 · 56 planned · Germany, United Kingdom
- Feb 20, 2026Phase 1 study in AsthmaNCT07433569 · 16 enrolled · United States
Ahead
- May 31, 2027Primary completion: phase 4 study in Pulmonary Disease, Chronic ObstructiveNCT07073950
- Dec 3, 2027Primary completion: phase 3 study in Pulmonary Disease, Chronic ObstructiveNCT06283966
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
The newest 60 of 63 AstraZeneca leads. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07433569Asthma · United States | 1 | Completed | Jun 26, 2026 | 16 |
| NCT07073950Pulmonary Disease, Chronic Obstructive · Germany, United Kingdom | 4 | Recruiting | May 31, 2027 | 56 |
| NCT06283966Pulmonary Disease, Chronic Obstructive · United States, Argentina, Australia and more | 3 | Recruiting | Dec 3, 2027 | 5,250 |
| NCT06067828Pulmonary Disease, Chronic Obstructive · United States, Canada, China and more | 3 | Completed | Jan 22, 2026 | 171 |
| NCT05755906Asthma · United States, Canada, Czechia and more | 3 | Completed | Nov 19, 2024 | 374 |
| NCT05202262Asthma · United States, Canada, Germany and more | 3 | Completed | Feb 26, 2025 | 645 |
| NCT04609904Asthma · United States, Brazil, China and more | 3 | Completed | Mar 20, 2025 | 2,187 |
| NCT04609878Asthma · United States, Argentina, Belgium and more | 3 | Completed | Mar 21, 2025 | 2,274 |
| NCT03836677Pulmonary Disease, Chronic Obstructive · Belgium, Netherlands | 3 | Completed | Nov 11, 2019 | 23 |
| NCT03162055Pulmonary Disease, Chronic Obstructive · United States, Bulgaria, Canada and more | 3 | Completed | May 4, 2018 | 1,119 |
| NCT03181880Pulmonary Disease, Chronic Obstructive | 4 | Withdrawn | Dec 3, 2018 | 0 |
| NCT03022097Pulmonary Disease, Chronic Obstructive · China, India, Philippines and more | 3 | Completed | Apr 14, 2022 | 1,625 |
| NCT02796651Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Dec 7, 2016 | 132 |
| NCT02796677Pulmonary Disease, Chronic Obstructive · United States, Bulgaria, Czechia and more | 3 | Completed | Jun 8, 2017 | 1,595 |
| NCT02766608Pulmonary Disease, Chronic Obstructive · United States, Canada, Czechia and more | 3 | Completed | Dec 1, 2017 | 2,389 |
| NCT03262012Pulmonary Disease, Chronic Obstructive · Japan | 3 | Completed | Jun 15, 2018 | 416 |
| NCT02685293Pulmonary Disease, Chronic Obstructive · United States | 3 | Terminated | Jun 6, 2018 | 4 |
| NCT02536508Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Sep 12, 2017 | 627 |
| NCT02497001Pulmonary Disease, Chronic Obstructive · United States, Canada, China and more | 3 | Completed | Jan 5, 2018 | 1,902 |
| NCT02465567Pulmonary Disease, Chronic Obstructive · United States, Argentina, Australia and more | 3 | Completed | Jul 26, 2019 | 8,588 |
| NCT02424344Pulmonary Disease, Chronic Obstructive · Canada, Germany, Hungary and more | 4 | Completed | Jul 25, 2016 | 267 |
| NCT02347085Pulmonary Disease, Chronic Obstructive | 3 | Completed | Jun 1, 2015 | 43 |
| NCT02347072Pulmonary Disease, Chronic Obstructive | 3 | Completed | Aug 1, 2015 | 80 |
| NCT02343458Pulmonary Disease, Chronic Obstructive · United States, China, Czechia and more | 3 | Completed | Aug 31, 2017 | 1,756 |
| NCT02196714Pulmonary Disease, Chronic Obstructive · United States | 1 | Completed | Sep 2014 | 24 |
| NCT02196077Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Mar 1, 2015 | 180 |
| NCT02189304Pulmonary Disease, Chronic Obstructive · United States | 1 | Completed | Sep 1, 2014 | 59 |
| NCT01908140Pulmonary Disease, Chronic Obstructive · Austria, Bulgaria, Canada and more | 3 | Completed | Aug 2014 | 933 |
| NCT01854658Pulmonary Disease, Chronic Obstructive · United States | 3 | Completed | Mar 2015 | 1,615 |
| NCT01641081Asthma · United States | 2 | Completed | Feb 2013 | 174 |
| NCT01551888Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Mar 2012 | 24 |
| NCT01349868Pulmonary Disease, Chronic Obstructive · United States | 2 | Completed | Jul 2011 | 50 |
| NCT01257048Pulmonary Disease, Chronic Obstructive · Sweden, United Kingdom | Early 1 | Completed | Jun 2012 | 34 |
| NCT01048333Pulmonary Disease, Chronic Obstructive · Italy, Spain, Sweden | 2 | Completed | May 2010 | 109 |
| NCT01047553Pulmonary Disease, Chronic Obstructive · Japan | 3 | Completed | Jan 2011 | 251 |
| NCT00989833Asthma, Exercise-Induced · Norway, Sweden | 2 | Completed | Jul 2010 | 66 |
| NCT00658255Stable Asthma | 2 | Completed | 175 | |
| NCT00652392Asthma | 3 | Completed | 750 | |
| NCT00652002Asthma | 3 | Completed | 450 | |
| NCT00651768Asthma | 3 | Completed | 570 | |
| NCT00651651Asthma | 3 | Completed | 450 | |
| NCT00651547Asthma | 3 | Completed | 405 | |
| NCT00646009Asthma | 3 | Completed | 48 | |
| NCT00628862Pulmonary Disease, Chronic Obstructive · Bulgaria, Japan, Romania and more | 3 | Completed | Apr 2009 | 613 |
| NCT00536913Asthma · Hungary, Poland, Russian Federation | 3 | Completed | Feb 2008 | 107 |
| NCT00489853Pulmonary Disease, Chronic Obstructive · Germany, Switzerland | 4 | Completed | Aug 2008 | 137 |
| NCT00463866Asthma · Belgium, Finland, France and more | 4 | Completed | 8,424 | |
| NCT00419744Pulmonary Disease, Chronic Obstructive · United States, Argentina, Brazil and more | 3 | Completed | Aug 2009 | 1,200 |
| NCT00326053Asthma · Canada | 3 | Completed | 600 | |
| NCT00319306Asthma · United Kingdom | 3 | Completed | 550 | |
| NCT00290264Asthma · Belgium, Luxembourg | 3 | Completed | 1,000 | |
| NCT00288379Asthma · Sweden | 3 | Completed | 16 | |
| NCT00272753Asthma · Netherlands | 4 | Completed | 20 | |
| NCT00259792Asthma · France | 3 | Completed | 1,000 | |
| NCT00259779Pulmonary Disease, Chronic Obstructive · Denmark, Finland, Germany and more | 3 | Completed | 120 | |
| NCT00255255Asthma · Japan | 3 | Completed | Dec 2006 | 120 |
| NCT00252785Asthma · Japan | 3 | Completed | 340 | |
| NCT00244608Asthma · Denmark, France, Germany and more | 3 | Completed | 100 | |
| NCT00242775Asthma · Argentina, Australia, Brazil and more | 3 | Completed | 2,100 | |
| NCT00238784Asthma · Canada | 3 | Completed | Oct 2005 | 1,300 |
How it is read
Names in the registry
- “Formoterol Fumarate”, 14 entries
- “budesonide/formoterol”, 10 entries
- “Formoterol”, 9 entries
- “Fluticasone Propionate/Formoterol Fumarate”, 9 entries
- “BGF MDI 320/14.4/9.6 μg”, 6 entries
Conditions, from the studies’ own filings
- Asthma, 75 studies
- Pulmonary Disease, Chronic Obstructive, 71 studies
- Bronchitis, Chronic, 2 studies
- Asthma, Exercise-Induced, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.